Intrathecal Pain Pumps for Cancer Pain: Effective, With Manageable Complication Rates

Intrathecal Pain Pumps for Cancer Pain: Effective, With Manageable Complication Rates

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published March 18, 2025 | Category: Pain Medicine

Up to 40% of people with cancer pain do not get adequate relief from medications, or cannot tolerate the side effects. Intrathecal pain pumps deliver small doses of medication directly into the spinal fluid and can provide strong relief with fewer side effects. But implanting a device in very ill patients raises safety concerns. A 2024 study in Neurosurgery reviewed long-term outcomes at a comprehensive cancer center.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors reviewed the records of all adult cancer patients who had an intrathecal pump implanted at their center between 2013 and 2021. They collected pain scores before and after implantation and recorded complications and reoperations.

What they found

  • 193 patients were included.
  • Average pain scores fell from 7.4 to 3.3 on a 10-point scale, and 95% of patients with follow-up scores reported less pain.
  • Median survival after pump placement was about 3.6 months.
  • 42 adverse events occurred in 33 patients. The 1-year cumulative incidence of any complication was 15.6%, and of severe complications 5.7%.
  • 11 patients needed reoperation, a 1-year incidence of 4.2%.

The authors conclude that intrathecal pumps are a safe and effective option for cancer-related pain.

Why this matters

Many patients with cancer pain have limited time, so a treatment must work quickly and safely. These results support offering pumps to carefully selected patients, while being honest that about one in six may experience a complication in the first year.

Limitations

This was a retrospective study from one specialized cancer center, which may not reflect results elsewhere. The abstract does not detail the specific types of complications.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Discuss expected benefits, complication rates and the possibility of reoperation during consent.
  • Plan for infection prevention, wound healing and bleeding risk in patients receiving chemotherapy or with low blood counts.
  • Arrange reliable follow-up for refills and dose adjustments, including in hospice settings.

For hospitals, clinics and safety leaders

  • Coordinate pump care across oncology, palliative care and pain services, with clear contacts for emergencies.

For patients and families

  • Ask who manages the pump, how refills work and what symptoms of overdose, withdrawal or infection to watch for.

Reference

  1. Winston GM, Zimering JH, Newman CW, Reiner AS, Manalil N, Kharas N, et al. Safety and Efficacy of Surgical Implantation of Intrathecal Drug Delivery Pumps in Patients With Cancer With Refractory Pain. Neurosurgery. 2024 Nov 01;95(5):1072-1081. doi:10.1227/neu.0000000000002978. PMID: 38700319. PubMed: https://pubmed.ncbi.nlm.nih.gov/38700319/

This article is educational information, not legal or medical advice.

Previous
Previous

Hardware Complications of Spinal Cord Stimulators: What Patients and Physicians Should Know

Next
Next

Light Sedation Did Not Distort Diagnostic Medial Branch Blocks